| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Karyopharm Therapeutics Inc. (KPTI) has 7 insiders with recent SEC Form 4 filings, including 0 buys and 10 sells. KPTI is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 198.3K | $1.91M | - | |
| VP | 79.5K | $767.2K | - | |
| VP | 67.4K | $650.3K | - | |
| VP | 65.1K | $628.0K | - | |
| VP | 56.3K | $543.2K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Oct 2, 2017 | Primiano Christopher Brett | SVP, Ops, Bus Dev, GC &Sec | Sell | 1,500 | $12.00 | $18,000.00 | -11.6% | |
| Sep 15, 2017 | Primiano Christopher Brett | SVP, Ops, Bus Dev, GC &Sec | Sell | 2,000 | $11.00 | $22,000.00 | -13.4% | |
| Sep 15, 2017 | Mirza Mansoor Raza79 | Director | Sale+OE | 2,882 | $11.00 | $31,702.00 | -100% | |
| Sep 11, 2017 | Mirza Mansoor Raza79 | Director | Sale+OE | 118 | $11.00 | $1,298.00 | -100% | |
| Aug 29, 2017 | Primiano Christopher Brett | SVP, Ops, Bus Dev, GC &Sec | Sell | 2,195 | $10.00 | $21,950.00 | -12.3% | |
| Jun 26, 2017 | Primiano Christopher Brett | SVP, Ops, Bus Dev, GC &Sec | Sell | 805 | $10.03 | $8,071.01 | -5.1% | |
| Nov 14, 2016 | Frenkel Ran78 | Chief Dev Operations Officer | Sell | 3,309 | $10.06 | $33,286.22 | -18.4% | |
| Nov 9, 2016 | Renz Justin A54 | EVP, CFO &Treasurer | Sell | 4,342 | $8.19 | $35,544.48 | -18.5% | |
| Nov 9, 2016 | Primiano Christopher Brett | SVP,Corp Dev,Gen Counsel&Sec. | Sell | 4,342 | $8.19 | $35,544.48 | -21.5% | |
| Jun 23, 2016 | Chione Ltd61 | 10% Owner | Sell | 18,824 | $8.03 | $151,083.31 | -0.2% |